(Q35970309)

English

Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

based on heuristic

inferred from title

author name string

Thomas Areschoug

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Fredric Carlsson

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Margaretha Stålhammar-Carlemalm

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Gunnar Lindahl

4

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

language of work or name

0 references

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

22 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

S9-S14

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Streptococcal M protein: molecular design and biological behavior.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Persistence of type-specific antibodies in man following infection with group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Human C4-binding protein. I. Isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

An IgA-binding peptide derived from a streptococcal surface protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Streptococcal IgA-binding Proteins Bind in the Cα2-Cα3 Interdomain Region and Inhibit Binding of IgA to Human CD89

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Isolation and detection of human IgA using a streptococcal IgA-binding peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Epidemic spread and antigenic variability of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Identification of a family of streptococcal surface proteins with extremely repetitive structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Mosaicism in the alpha-like protein genes of group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Immunogenicity of a 26-valent group A streptococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

New protective antigen of group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Protective Immune Response againstStreptococcus pyogenesin Mice after Intranasal Vaccination with the Fibronectin‐Binding Protein SfbI

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

The IgA-binding β antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

C5a peptidase alters clearance and trafficking of group A streptococci by infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.08.010

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35970309&oldid=1963233170"